Toevoegen aan een lijst
Financiën Bloomage BioTechnology Corporation Limited
Aandelen
688363
CNE100003NL9
Farmaceutische producten
|
Slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 50,38 CNY | -0,92% |
|
-7,83% | -1,29% |
Voorlopige winst- en verliesrekening: Bloomage BioTechnology Corporation Limited
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 2.633 | 4.948 | 6.359 | 6.076 | 5.371 | 5.864 | 6.751 | 7.544 |
| Variatie | - | 87,93% | 28,53% | -4,45% | -11,6% | 9,18% | 15,13% | 11,74% |
| EBITDA 1 | 832,1 | 1.033 | 1.314 | 941,4 | 485,3 | 922 | 1.217 | 1.386 |
| Variatie | - | 24,15% | 27,21% | -28,36% | -48,45% | 89,97% | 32,01% | 13,87% |
| Bedrijfsresultaat (EBIT) 1 | 757 | 905,6 | 1.136 | 708,4 | 210,2 | 587,4 | 789,5 | 978,4 |
| Variatie | - | 19,62% | 25,48% | -37,66% | -70,33% | 179,49% | 34,39% | 23,93% |
| Betaalde rente 1 | 0,5115 | 0,4947 | 48,66 | -30,79 | -6,955 | -6,99 | -22,59 | -40,84 |
| Resultaat voor belastingen (EBT) 1 | 758,9 | 890,2 | 1.136 | 701,7 | 207,7 | 575,9 | 787,9 | 980,3 |
| Variatie | - | 17,3% | 27,62% | -38,23% | -70,4% | 177,3% | 36,79% | 24,42% |
| Nettowinst (verlies) 1 | 645,8 | 782,3 | 970,9 | 592,6 | 164,3 | 489,6 | 659,1 | 816 |
| Variatie | - | 21,13% | 24,11% | -38,97% | -72,27% | 197,93% | 34,64% | 23,79% |
| Datum van publicatie | 25/02/21 | 25/02/22 | 27/02/23 | 29/02/24 | 27/02/25 | - | - | - |
1CNY in Miljoen
Geschatte gegevens
Balansprognose: Bloomage BioTechnology Corporation Limited
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuld 1 | - | -1.576 | -1.269 | -1.013 | -513 | -1.307 | -1.629 | -1.169 |
| Variatie | - | - | 19,48% | 20,17% | 49,36% | -155% | -24,64% | 28,24% |
| Datum van publicatie | 25/02/21 | 25/02/22 | 27/02/23 | 29/02/24 | 27/02/25 | - | - | - |
1CNY in Miljoen
Geschatte gegevens
Verwachte kasstroom: Bloomage BioTechnology Corporation Limited
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 762,7 | 784,2 | 695,2 | 1.030 | 721,2 | 590 | 491,9 | 501,2 |
| Variatie | - | 2,82% | -11,35% | 48,21% | -30,01% | -18,19% | -16,63% | 1,89% |
| Vrije kasstroom (FCF) 1 | - | 491,9 | -59,98 | -330,7 | -156,7 | -827 | -2.656 | -3.947 |
| Variatie | - | - | -112,19% | -451,31% | 52,62% | -427,85% | -221,16% | -48,61% |
| Datum van publicatie | 25/02/21 | 25/02/22 | 27/02/23 | 29/02/24 | 27/02/25 | - | - | - |
1CNY in Miljoen
Geschatte gegevens
Verwachte financiële ratio's: Bloomage BioTechnology Corporation Limited
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
| EBITDA-marge (%) | 31,6% | 20,88% | 20,66% | 15,49% | 9,04% | 15,72% | 18,03% | 18,37% |
| EBIT-marge (%) | 28,76% | 18,3% | 17,87% | 11,66% | 3,91% | 10,02% | 11,69% | 12,97% |
| EBT-marge (%) | 28,83% | 17,99% | 17,87% | 11,55% | 3,87% | 9,82% | 11,67% | 12,99% |
| Nettomarge (%) | 24,53% | 15,81% | 15,27% | 9,75% | 3,06% | 8,35% | 9,76% | 10,82% |
| FCF-marge (%) | - | 9,94% | -0,94% | -5,44% | -2,92% | -14,1% | -39,34% | -52,32% |
| Vrije kasstroom/nettoresultaat (%) | - | 62,87% | -6,18% | -55,81% | -95,35% | -168,93% | -402,95% | -483,72% |
Winstgevendheid | ||||||||
| ROA | 12,09% | 11,84% | 12% | 6,86% | 1,92% | 5,9% | 7,03% | 8,8% |
| ROE | 13,46% | 14,6% | 15,75% | 8,31% | 2,34% | 6,76% | 8,33% | 9,6% |
Financiële gezondheid | ||||||||
| Hefboom (schuld/ebitda) | - | - | - | - | - | - | - | - |
| Schuld/vrije kasstroom | - | - | - | - | - | - | - | - |
Kapitaalintensiteit | ||||||||
| Kapitaaluitgaven/omzet (%) | 28,97% | 15,85% | 10,93% | 16,96% | 13,43% | 10,06% | 7,29% | 6,64% |
| CAPEX / EBITDA (%) | 91,66% | 75,92% | 52,9% | 109,44% | 148,59% | 63,99% | 40,41% | 36,16% |
| CAPEX / FCF (%) | - | 159,44% | -1.158,97% | -311,58% | -460,31% | -71,34% | -18,52% | -12,7% |
Bestanddelen per aandeel | ||||||||
| Kasstroom per aandeel 1 | 1,469 | 2,642 | 1,32 | 1,452 | 1,172 | 1,929 | 2,174 | 2,533 |
| Variatie | - | 79,88% | -50,03% | 10,01% | -19,31% | 64,58% | 12,7% | 16,54% |
| Dividend per aandeel 1 | 0,41 | 0,49 | 0,61 | 0,38 | 0,11 | 0,3346 | 0,442 | 0,5369 |
| Variatie | - | 19,51% | 24,49% | -37,7% | -71,05% | 204,19% | 32,11% | 21,46% |
| Nettoactief per aandeel 1 | 10,46 | 11,87 | 13,79 | 14,42 | 14,13 | 14,98 | 16,12 | 16,85 |
| Variatie | - | 13,5% | 16,17% | 4,55% | -1,99% | 5,99% | 7,6% | 4,53% |
| WPA 1 | 1,35 | 1,62 | 2,01 | 1,23 | 0,34 | 1,025 | 1,37 | 1,677 |
| Variatie | - | 20% | 24,07% | -38,81% | -72,36% | 201,59% | 33,62% | 22,39% |
| Aantal aandelen (in duizend) | 480.000 | 480.000 | 481.085 | 481.678 | 478.363 | 478.363 | 478.363 | 478.363 |
| Datum van publicatie | 25/02/21 | 25/02/22 | 27/02/23 | 29/02/24 | 27/02/25 | - | - | - |
1CNY
Geschatte gegevens
| 2025 * | 2026 * | |
|---|---|---|
| k/w-verhouding | 49,1x | 36,8x |
| PBR-ratio | 3,36x | 3,13x |
| EV/omzet | 3,89x | 3,33x |
| Dividendrendement | 0,66% | 0,88% |
Meer waarderingsratio's
* Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
13
Laatste slotkoers
50,38CNY
Gemiddelde koersdoel
57,24CNY
Spread / Gemiddelde doel
+13,63%
Kwartaalomzet - Afwijkingspercentage
- Beurs
- Aandelen
- Koers 688363
- Financiën Bloomage BioTechnology Corporation Limited
Kies jouw editie
Alle financiële informatie op nationaal niveau
